[ALNY] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
05-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 5.00%
YoY- -4.19%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 99,476 33,294 21,899 18,960 7,345 18,537 8,275 51.29%
PBT -181,646 -181,220 -141,276 -107,290 -102,974 -51,208 -268,813 -6.31%
Tax 575 695 -62 -2,128 -6,414 -431 -17,870 -
NP -182,221 -181,915 -141,214 -107,290 -102,974 -50,777 -250,943 -5.18%
Tax Rate - - - - - - - -
Total Cost 281,697 215,209 163,113 126,250 110,319 69,314 259,218 1.39%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -183.18 -546.39 -644.84 -565.88 -1,401.96 -273.92 -3,032.54 -37.33%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.62 -1.73 -1.41 -1.25 -1.21 -0.62 -3.70 -12.84%
EPS Diluted -1.62 -1.73 -1.41 -1.25 -1.21 -0.62 -3.70 -12.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.